Abstract | OBJECTIVE: METHODS: A total of 48 patients with primary liver cancer, who failed to be treated by major surgery, were randomly divided into two groups: Jinlong Capsule group (TACE therapy plus Jinlong Capsule) and control group (TACE therapy alone). There were 24 cases in each group. The levels of peripheral blood IL-2 and slL-2R were measured before the first TACE and 1, 7 and 15 days after the second TACE respectively by using double-antibody sandwich enzyme-linked immunosorbent assay. The data from Jinlong Capsule group were compared with those from the control group. RESULTS: The level of sIL-2R in Jinlong Capsule group was significantly lower than that in the control group (P<0.05), while the level of IL-2 was significantly higher than that in the control group (P<0.05). CONCLUSION:
|
Authors | Huo-Jun Zhang, Ji-Jin Yang, Wei-Xing Wang, Xu Jiang, Yan-Jun Mao, Chao-Ai Yang, Ji-Xiang Guo |
Journal | Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine
(Zhong Xi Yi Jie He Xue Bao)
Vol. 6
Issue 9
Pg. 907-10
(Sep 2008)
ISSN: 1672-1977 [Print] China |
PMID | 18782532
(Publication Type: English Abstract, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Adjuvants, Immunologic
- Capsules
- Drugs, Chinese Herbal
- IL2 protein, human
- Interleukin-2
- Receptors, Interleukin-2
|
Topics |
- Adjuvants, Immunologic
(therapeutic use)
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage)
- Capsules
- Carcinoma, Hepatocellular
(blood, drug therapy)
- Chemoembolization, Therapeutic
(methods)
- Drug Therapy, Combination
- Drugs, Chinese Herbal
(therapeutic use)
- Female
- Humans
- Interleukin-2
(blood)
- Liver Neoplasms
(blood, drug therapy)
- Male
- Middle Aged
- Phytotherapy
- Receptors, Interleukin-2
(blood)
|